Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05399446 · ClinicalTrials.gov registry record · NA
Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes
A NA study of Type 1 Diabetes and Eating Disorders, sponsored by Oslo University Hospital.
- Active
- Registry status
- NA
- Development phase
- 280
- Enrollment target
- 4
- Study locations
NCT05399446: Active NA study of Type 1 Diabetes and Eating Disorders, sponsored by Oslo University Hospital.
NCT05399446 is a NA study of Type 1 Diabetes and Eating Disorders that is active but no longer recruiting, run by Oslo University Hospital. The registered enrollment target is 280 participants, below the 765-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (63% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05399446, a NA study of Type 1 Diabetes and Eating Disorders, is active but no longer recruiting, sponsored by Oslo University Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study aims to test the effectiveness of an evidence-based eating-disorder prevention program specifically targeted for individuals with Type 1 Diabetes (T1D) compared to an educational control group. The Diabetes Body Project (DBP), is an adaptation of the Body Project which is the only eating disorder prevention program to have repeatedly produced effects when evaluated by independent researchers, produced stronger effects than credible alternative interventions, and affected objective outcomes. DBP has been adapted slightly for individuals with T1D who are at ultra-high risk for eating disorders. The study aims to test the effectiveness of the DBP of reducing body image concerns and reducing eating pathology and improving glycemic control.
Primary Outcome
Assessed with the 8-item Ideal-Body Stereotype Scale-Revised (Stice et al., 2017) which measures pursuit of the thin ideal. Each item is scored on a scale of 1 = strongly disagree to 5 = strongly agree. Higher scores indicate greater belief in the thin-deal.
Conditions Studied
Interventions
- BEHAVIORAL Diabetes Body Project
- BEHAVIORAL Educational Group
Study Locations (4)
Other
- Amsterdam Medical University Center - Amsterdam
- Oslo University Hospital - Oslo
California
- Stanford University - Stanford
Massachusetts
- Joslin Diabetes Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2027-01 |
| Phase | NA |
What the registry record for NCT05399446 still lists
NCT05399446 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, below the 765-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (63% lower).
The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Diabetes Body Project is the first listed.
NCT05399446 reports a single indexed study location in Other, California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05399446 about?
NCT05399446 is a clinical study titled "Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes". This study aims to test the effectiveness of an evidence-based eating-disorder prevention program specifically targeted for individuals with Type 1 Diabetes (T1D) compared to an educational control group. The Diabetes Body Project (DBP), is an adaptation of the Body Project which is the only eating ...
What is the current status of trial NCT05399446?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2023-01-01. Estimated completion is 2027-01.
What conditions does trial NCT05399446 study?
This clinical trial studies the following conditions: Type 1 Diabetes, Eating Disorders.
What interventions are being tested in trial NCT05399446?
The interventions under investigation include: Diabetes Body Project (BEHAVIORAL), Educational Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05399446?
This trial is sponsored by Oslo University Hospital, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05399446 being conducted?
This trial has 4 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05399446's enrollment target sits among peer trials
280 23rd of 198 higher than 175 of 198 other Type 1 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
AIDANET Pediatrics
RECRUITING · NA
-
A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
-
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04084730 · 280 participants · Phase 2
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- NCT04518657 · 280 participants · NA
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
- NCT04634916 · 280 participants · NA
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- NCT04829617 · 280 participants · NA
Promoting Well-being and Health in Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI